It is a pharma public limited company based in New Delhi, Delhi, India, established in 2008.
2008 | New Delhi, Delhi, India | ActiveEos Pharmaceuticals India Limited, a active public limited company, was established on 24 December 2008 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24232DL2008PLC186122. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Formerly known as Acme Pharmaceuticals India Limited. It upholds a compliant status. Employing 6 professional, Its leadership includes Bhushan Nanda (Director), Vishal Nanda (Managing Director), Monika Nanda (Director). Past directors included Vishal Nanda. It holds ₹8.42 M open charges and no settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at M-142, Vikas Puri, New Delhi, Delhi, 110018.
U24232DL2008PLC186122
186122
24 December 2008
₹0.50 M
₹0.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Eos Pharmaceuticals India Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhushan Nanda | Director | 24 Dec 2008 | Current |
| Vishal Nanda | Managing Director | 24 Dec 2008 | Current |
| Monika Nanda | Director | 24 Dec 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eos Pharmaceuticals India Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 34.99% decrease. The company also saw a substantial fall in profitability, with a 48.94% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Eos Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹8,416,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2020 | Others | ₹0.92 M | Open |
| 21 Jun 2017 | Others | ₹3.50 M | Open |
| 19 Jun 2017 | Others | ₹1.50 M | Open |
| 29 May 2009 | Capital Local Area Bank Limited | ₹2.50 M | Open |
Explore comprehensive loan charge details -
Eos Pharmaceuticals India has a workforce of 6 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Eos Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eos Pharmaceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Eos Pharmaceuticals India Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
Eos Pharmaceuticals India Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.92 M with Charge ID 100362453 was registered on 27 Jul 2020. was completed.
The activity A charge with Others amounted to Rs. 3.50 M with Charge ID 100121292 was registered on 21 Jun 2017. was completed.
The activity A charge with Others amounted to Rs. 1.50 M with Charge ID 100121164 was registered on 19 Jun 2017. was completed.
The activity A charge with Capital Local Area Bank Limited of Rs. 2.50 M registered on 29 May 2009 with Charge ID 10162140 was modified on 03 Oct 2013. was completed.
The CIN of Eos Pharmaceuticals India Limited is U24232DL2008PLC186122.
Eos Pharmaceuticals India Limited is headquartered at M-142, Vikas Puri, New Delhi, Delhi, 110018.
Eos Pharmaceuticals India Limited was incorporated on 24 December 2008.
The current directors of Eos Pharmaceuticals India Limited are
The primary industry of Eos Pharmaceuticals India Limited is Manufacturing.
Eos Pharmaceuticals India Limited is unlisted.
The authorized capital of Eos Pharmaceuticals India Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Eos Pharmaceuticals India Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX